Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSL1900088	注射用曲妥珠单抗	trastuzumab	Lyophilized	Biological Products	Import Drug Application	2019-09-11	上海艾迈医疗科技有限公司	Shanghai AffaMed Therapeutics Co Ltd;Samsung Bioepis Co Ltd	In Review	2019-09-10	view
JXSL2000131	雷珠单抗注射液	ranibizumab	Injection	Biological Products(3.3)	Import Drug Application	2020-07-17	上海艾迈医疗科技有限公司	Shanghai AffaMed Therapeutics Co Ltd;Affamed Therapeutics (HK) Ltd	In Review	2020-07-16	view
JXHL2100066	AM006	AM-006	Active ingredient	Chemical Drugs(1)	Import Drug Application	2021-03-02	上海艾迈医疗科技有限公司	Shanghai AffaMed Therapeutics Co Ltd;Affamed Therapeutics (HK) Ltd	In Review	2021-03-01	view
JXHL2100065	AM006	AM-006	Active ingredient	Chemical Drugs(1)	Import Drug Application	2021-03-02	上海艾迈医疗科技有限公司	Shanghai AffaMed Therapeutics Co Ltd;Affamed Therapeutics (HK) Ltd	In Review	2021-03-01	view